Bayer abandons key provision in glyphosate settlement plan

Two weeks after agreeing to pay up to $9.6 billion to resolve thousands of cancer lawsuits against glyphosate, seed and ag-chemical giant Bayer is still looking for a way to handle future litigation against the weedkiller. A proposal to appoint a panel of experts to decide if glyphosate is carcinogenic — a pivotal question for… » Read More

The Ag Insider content is only available to members.
Exit mobile version